サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1623511

呼吸器診断の世界市場規模：検査タイプ別、製品・サービス別、エンドユーザー別、地域別、範囲および予測

Global Respiratory Diagnostics Market Size By Test Type, By Products And Services, By End User, By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
呼吸器診断の世界市場規模：検査タイプ別、製品・サービス別、エンドユーザー別、地域別、範囲および予測
出版日: 2024年10月17日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

呼吸器診断の市場規模と予測

呼吸器診断市場規模は、2020年に46億9,000万米ドルと評価され、2021年から2028年にかけてCAGR 6.3%で成長し、2028年には79億9,000万米ドルに達すると予測されます。

肺に関連する疾患や感染症の増加、高齢者人口の増加、技術開発などの要因が市場の成長につながっています。一方、償還やヘルスケアコストの上昇に関連するリスクは、市場全体の成長を阻害する可能性があります。呼吸器診断の世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

呼吸器診断の世界市場定義

呼吸器診断は、医療分野や診断センターで最も使用されている技術の1つです。市場成長の主な理由は、若年層におけるライフスタイルの変化と、老年層における加齢に関連した症状や疾患です。

呼吸器診断の世界市場概要

肺に関連する疾患や感染症の増加、老年人口の増加、技術開発などの要因が市場の成長につながっています。一方、診療報酬やヘルスケアコストの上昇に関連するリスクは、市場全体の成長を阻害する可能性があります。喫煙者の増加やアルコールの消費、座りっぱなしの生活習慣やストレスの多い日常生活は、COPDや肺がんなどの重症呼吸器疾患の発生率の増加をもたらしています。さらに、COPDの診断や外来患者の管理に人工知能（AI）やモノのインターネット（IoT）を使用することを数える呼吸器診断検査におけるいくつかの技術革新が、市場の成長にプラスの影響を与えています。

市場成長の妨げとなる一定の抑制要因や課題も存在します。COPDの診断と検査に関連する高価格、診断されず治療を受けていない多くの人口の存在、厳しい規制要件、認識不足、償還に関する懸念などの要因が、世界の呼吸器診断市場の成長を抑制すると予想されます。

目次

第1章 呼吸器診断の世界市場：イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の呼吸器診断市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 規制の枠組み

第5章 呼吸器診断の世界市場：検査タイプ別

  • 概要
  • 機械的検査
  • OSA診断検査
  • 画像検査
  • 分子診断検査
  • その他

第6章 呼吸器診断の世界市場：製品・サービス別

  • 概要
  • 機器・デバイス
  • アッセイと試薬
  • サービスとソフトウェア

第7章 呼吸器診断の世界市場：エンドユーザー別

  • 概要
  • 病院／臨床検査室
  • リファレンスラボ
  • 医師事務所
  • その他のエンドユーザー

第8章 呼吸器診断の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第9章 呼吸器診断の世界市場：競合情勢

  • 概要
  • 企業市場ランキング
  • ベンダー情勢
  • 主な発展戦略

第10章 企業プロファイル

  • Philips Healthcare
  • Becton, Dickinson & Company
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • Cosmed
  • Seegene Inc.
  • Sdi Diagnostic

第11章 付録

  • 関連調査
目次
Product Code: 23977

Respiratory Diagnostics Market Size And Forecast

Respiratory Diagnostics Market size was valued at USD 4.69 Billion in 2020 and is projected to reachUSD 7.99 Billion by 2028, growing at aCAGR of 6.3% from 2021 to 2028.

Factors such as increasing lung-related diseases and infections, the rise in the geriatric population, and technological developments are leading to growth in the market. On the other hand, risks associated with reimbursements and the rising healthcare cost might hinder the overall market growth. The Global Respiratory Diagnostics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Respiratory Diagnostics Market Definition

Respiratory Diagnostics is one of the most used technologies in the medicinal sector and diagnostic centers. The reason for the market growth is mainly the lifestyle changes in the young population and age-related symptoms and diseases in the geriatric population.

Global Respiratory Diagnostics Market Overview

Factors such as increasing lung-related diseases and infections, the rise in the geriatric population and technological developments are leading to the growth in the market. On the other hand, risks associated with reimbursements and the rising healthcare cost might hinder the overall market growth. The growing number of smokers and consumption of alcohol, along with sedentary lifestyle habits and stressful routines, have resulted in increased incidences of COPD and other severe respiratory conditions, such as lung cancer. Moreover, several technological innovations in respiratory diagnostic testing, counting the use of Artificial Intelligence (AI) and the Internet of Things (IoT) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth.

There are certain restraints and challenges faced which will hinder the market growth. Factors such as High price associated with COPD diagnosis and testing, a presence of a large population going undiagnosed and undertreated, Strict regulatory requirements, lack of awareness, and Reimbursement concerns are expected to restrain the growth of the global Respiratory Diagnostics Market.

Global Respiratory Diagnostics Market: Segmentation Analysis

Global Respiratory Diagnostics Market is segmented based on Test Type, Products and Services, End User, And Geography.

Respiratory Diagnostics Market, By Test Type

  • Mechanical Tests
  • OSA Diagnostic Tests
  • Imaging Tests
  • Molecular Diagnostic Tests
  • Others

Based on Test Type, the market is bifurcated into Mechanical Tests, OSA Diagnostic Tests, Imaging Tests, Molecular Diagnostic Tests, and Others. The OSA Diagnostic Tests segment is projected to account for the largest share of the market. The factors can be attributed to the quick turnaround time of these tests.

Respiratory Diagnostics Market, By Products And Services

  • Instruments and Devices
  • Assays and Reagents
  • Services and Software

Based on Products and Services, the market is bifurcated into Instruments and Devices, Assays and Reagents and Services & Software. The instruments and devices segment is anticipated to account for the largest share in the market. The factors can be attributed to the continuous requirement of diagnostic instruments and devices in point-of-care, laboratories, and home care.

Respiratory Diagnostics Market, By End User

  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Physician Offices
  • Other End Users

Based on End User, the market is bifurcated into Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices and Other End Users. The Hospital/Clinical Laboratories segment is expected to account for the largest share of the global market due to most respiratory disease diagnostics are done in hospitals as they are complex and need technologically advanced products this factor is driving the market for Hospital/Clinical Laboratories.

Respiratory Diagnostics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global Respiratory Diagnostics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by North America. The factors can be attributed to the growing prevalence of respiratory diseases and the increasing geriatric population in the region. Furthermore, the occurrence of an advanced healthcare system and robust distribution channels for respiratory diagnostic products are other factors supporting the growth of this market in North America.

Key Players

  • The "Global Respiratory Diagnostics Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
  • Philips Healthcare, Becton, Dickinson & Company, Abbott Laboratories, Thermo Fisher Scientific Inc., Alere Inc., Bio-Rad Laboratories, Inc., Cosmed, Seegene Inc. and Sdi Diagnostic.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Product Launches and Product Expansions
  • In June 2020, GE Healthcare launched the Thoracic Care Suite that has eight artificial intelligence (AI) algorithms that allow chest X-rays to detect abnormalities, including pneumonia detection, a symptom related to COVID-19. This new product launched by the company during the expansion of COVID-19 has enhanced the credibility of the company in the market.
  • On July 2020 BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, has announced the launch of three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses.
  • May 2020, Australian medical technology company, 4DMedical has received clearance from the US Food & Drug Administration to market its XV Technology, a patented four-dimensional lung imaging process that rapidly and automatically analyses any functional lung impairment from a single X-ray. 4DMedical's US operations are based in Woodland Hills, California.
  • Acquisition and Mergers
  • May 2020, SIME, a Clinical AI company specialising in rapid ICU diagnostics, announced it has entered into an exclusive agreement with an existing strategic investor to commercialise the company's point-of-care products and services in Latin America.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL RESPIRATORY DIAGNOSTICS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL RESPIRATORY DIAGNOSTICS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE

  • 5.1 Overview
  • 5.2 Mechanical Tests
  • 5.3 OSA Diagnostic Tests
  • 5.4 Imaging Tests
  • 5.5 Molecular Diagnostic Tests
  • 5.6 Others

6 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES

  • 6.1 Overview
  • 6.2 Instruments & Devices
  • 6.3 Assays and Reagents
  • 6.4 Services and Software

7 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY END USER

  • 7.1 Overview
  • 7.2 Hospital/Clinical Laboratories
  • 7.3 Reference Laboratories
  • 7.4 Physician Offices
  • 7.5 Other End Users

8 GLOBAL RESPIRATORY DIAGNOSTICS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL RESPIRATORY DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market ranking
  • 9.3 Vendor Landscape
  • 9.4 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Philips Healthcare
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Becton, Dickinson & Company
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Abbott Laboratories
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Thermo Fisher Scientific Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Alere Inc.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Bio-Rad Laboratories, Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Cosmed
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Seegene Inc.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Sdi Diagnostic
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments

11 APPENDIX

  • 11.1 Related Research